Iwasaki, A. Antiviral immune responses in the genital tract: clues for vaccines. Nat. Rev. Immunol. 10, 699–711 (2010).
Ichinohe, T., Iwasaki, A. & Hasegawa, H. Innate sensors of influenza virus: clues to developing better intranasal vaccines. Expert Rev. Vaccines 7, 1435–1445 (2008).
Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature 449, 819–826 (2007).
Kawai, T. & Akira, S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637–650 (2011).
Janeway, C.A. Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54, 1–13 (1989).
Lund, J., Sato, A., Akira, S., Medzhitov, R. & Iwasaki, A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198, 513–520 (2003).
Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101–105 (2006).
Okabe, Y., Kawane, K., Akira, S., Taniguchi, T. & Nagata, S. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 202, 1333–1339 (2005).
Imai, Y. et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133, 235–249 (2008).
Gupta, R., Warren, T. & Wald, A. Genital herpes. Lancet 370, 2127–2137 (2007).
Kurt-Jones, E.A. et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. USA 101, 1315–1320 (2004).
Sørensen, L.N. et al. TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J. Immunol. 181, 8604–8612 (2008).
Reinert, L.S. et al. TLR3-deficiency renders astrocytes permissive to HSV infection and facilitates establishment of CNS infection in mice. J. Clin. Invest. 122, 1368–1376 (2012).
Melchjorsen, J. et al. Innate recognition of HSV in human primary macrophages is mediated via the MDA5/MAVS pathway and MDA5/MAVS/Pol III independent pathways. J. Virol. 84, 11350–11358 (2010).
Ishikawa, H., Ma, Z. & Barber, G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788–792 (2009).
Li, X.D. et al. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341, 1390–1394 (2013).
Paludan, S.R., Bowie, A.G., Horan, K.A. & Fitzgerald, K.A. Recognition of herpesviruses by the innate immune system. Nat. Rev. Immunol. 11, 143–154 (2011).
Crotta, S. et al. Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog. 9, e1003773 (2013).
Leib, D.A. et al. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189, 663–672 (1999).
Mordstein, M. et al. Interferon-λ renders epithelial cells of respiratory and gastrointestinal tract resistant to viral infections. J. Virol. 84, 5670–5677 (2010).
Zhao, X. et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective TH1 responses to herpes simplex virus-2. J. Exp. Med. 197, 153–162 (2003).
Groom, J.R. & Luster, A.D. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 89, 207–215 (2011).
Cheshenko, N. et al. HSV activates Akt to trigger calcium release and promote viral entry: novel candidate target for treatment and suppression. FASEB J. 27, 2584–2599 (2013).
Radhakrishnan, P. et al. Immature truncated O-glycophenotype of cancer directly induces oncogenic features. Proc. Natl. Acad. Sci. USA 111, E4066–E4075 (2014).
Bagdonaite, I. et al. A strategy for O-glycoproteomics of enveloped viruses–the O-glycoproteome of herpes simplex virus type 1. PLoS Pathog. 11, e1004784 (2015).
McGuckin, M.A., Linden, S.K., Sutton, P. & Florin, T.H. Mucin dynamics and enteric pathogens. Nat. Rev. Microbiol. 9, 265–278 (2011).
Harrington, S.M. et al. The Pic protease of enteroaggregative Escherichia coli promotes intestinal colonization and growth in the presence of mucin. Infect. Immun. 77, 2465–2473 (2009).
Frazer, L.C., O'Connell, C.M., Andrews, C.W. Jr., Zurenski, M.A. & Darville, T. Enhanced neutrophil longevity and recruitment contribute to the severity of oviduct pathology during Chlamydia muridarum infection. Infect. Immun. 79, 4029–4041 (2011).
Archer, N.K., Harro, J.M. & Shirtliff, M.E. Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx. Infect. Immun. 81, 2070–2075 (2013).
Milligan, G.N. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2. J. Virol. 73, 6380–6386 (1999).
Jenne, C.N. et al. Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps. Cell Host Microbe 13, 169–180 (2013).
Ohmori, Y., Schreiber, R.D. & Hamilton, T.A. Synergy between interferon-γ and tumor necrosis factor-α in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor-κB. J. Biol. Chem. 272, 14899–14907 (1997).
Ohmori, Y. & Hamilton, T.A. The interferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-α. J. Immunol. 154, 5235–5244 (1995).
Hollingsworth, M.A. & Swanson, B.J. Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 4, 45–60 (2004).
Dodds, P.N. & Rathjen, J.P. Plant immunity: towards an integrated view of plant-pathogen interactions. Nat. Rev. Genet. 11, 539–548 (2010).
Pinheiro, J.C. & Bates, D.M. in Mixed Effects Models in S and S-PLUS 273–301 (Springer, 2000).